Ethel Cesarman, Weill Cornell Medicine, USA
Ethel Cesarman’s, research focuses on elucidating the molecular pathogenesis of B cell lymphomas and other malignancies associated with AIDS and other immunodeficiencies. Her work has contributed to our understanding of herpesviral oncogenesis, including the discovery of KSHV/HHV-8 as the causal agent of Kaposi’s sarcoma. She led the studies that uncovered the presence of KSHV in a specific subset of lymphomas defining distinct cancer entity called primary effusion lymphoma (PEL), now a well recognized clinical entity. She has been involved in supervising the pathologic diagnosis of Kaposi’s sarcoma and lymphoma in Africa, and improving the diagnostic methodologies by developing new point-of-care assays.
« Go Back